This week's episode focuses on metastatic non-small cell lung cancer - the quickly growing and changing systemic therapy landscape, including traditional chemotherapy, immunotherapy, and targeted agents. Since our last recording the number of FDA-approved targeted drugs has significantly expanded.
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from Two Onc Docs
Breast Cancer Screening, Prevention & Intro 2026 UPDATE
ctDNA & MRD: Current Applications, Limitations & What’s Next
ctDNA, Liquid Biopsies, Methylation, NGS: What Does It All Mean?
Non-Small Cell Lung Cancer 2026 UPDATE
Get summaries like this every morning.
Free AI-powered recaps of Two Onc Docs and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.